Mahamaya Lifesciences Limited (BOM:544611)
India · Delayed Price · Currency is INR 175.00
0.00 (0.00%)
At close: Jun 15, 2026
Mahamaya Lifesciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 165.23 | 128.12 | 53.76 | 37.51 | 27.23 |
Depreciation & Amortization | 22.42 | 12.92 | 9.62 | 8.46 | 8.22 |
Other Amortization | - | 5.18 | 4.45 | 4.26 | 1.37 |
Loss (Gain) From Sale of Assets | 0.09 | -0.28 | -0.18 | -0.21 | - |
Other Operating Activities | 106.77 | 91.42 | 65.05 | 37 | 16.54 |
Change in Accounts Receivable | -222.97 | -201.54 | -187.81 | -4.22 | -26.95 |
Change in Inventory | -408.45 | -491.84 | -162.46 | -161.46 | -59.25 |
Change in Accounts Payable | 93.73 | 324.1 | -44.06 | 105.02 | 90.03 |
Change in Other Net Operating Assets | -52.07 | 98.86 | 27.02 | -15.12 | -35.58 |
Operating Cash Flow | -295.24 | -33.05 | -234.6 | 11.24 | 21.62 |
Operating Cash Flow Growth | - | - | - | -47.99% | - |
Capital Expenditures | -88.08 | -50.44 | -15.13 | -28.94 | -32.69 |
Sale of Property, Plant & Equipment | 1.04 | 3.66 | 0.5 | 0.4 | - |
Sale (Purchase) of Intangibles | -72.93 | - | - | - | - |
Other Investing Activities | 4.01 | 2.03 | 0.84 | 0.03 | 0.15 |
Investing Cash Flow | -155.96 | -44.75 | -13.79 | -28.51 | -32.53 |
Short-Term Debt Issued | 352.15 | 113.29 | 322.93 | - | - |
Long-Term Debt Issued | - | - | 6.39 | 2,277 | 79.95 |
Total Debt Issued | 352.15 | 113.29 | 329.32 | 2,277 | 79.95 |
Short-Term Debt Repaid | - | -59.17 | -2.91 | - | - |
Long-Term Debt Repaid | -25.92 | -20.03 | -23.91 | -2,225 | -49.91 |
Total Debt Repaid | -25.92 | -79.2 | -26.82 | -2,225 | -49.91 |
Net Debt Issued (Repaid) | 326.23 | 34.09 | 302.5 | 52.07 | 30.04 |
Issuance of Common Stock | 642.82 | 137.94 | - | - | - |
Other Financing Activities | -163.81 | -87.36 | -57.23 | -28.52 | -16.27 |
Financing Cash Flow | 805.24 | 84.67 | 245.27 | 23.55 | 13.77 |
Miscellaneous Cash Flow Adjustments | - | - | 0 | - | - |
Net Cash Flow | 354.04 | 6.86 | -3.12 | 6.28 | 2.86 |
Free Cash Flow | -383.32 | -83.49 | -249.73 | -17.7 | -11.07 |
Free Cash Flow Margin | -11.66% | -3.16% | -15.46% | -1.29% | -1.23% |
Free Cash Flow Per Share | -19.32 | -4.92 | -18.18 | -1.29 | -0.81 |
Cash Interest Paid | 81.39 | 68.08 | 57.23 | 28.52 | 16.27 |
Cash Income Tax Paid | 43.62 | 18.6 | 11.86 | 10.56 | 12.07 |
Levered Free Cash Flow | -574.17 | -130.13 | -305.05 | -39.34 | - |
Unlevered Free Cash Flow | -523.31 | -95.68 | -276.27 | -22.89 | - |
Change in Working Capital | -589.76 | -270.42 | -367.31 | -75.78 | -31.74 |